vs
NLIGHT, INC.（LASR）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
NLIGHT, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$81.2M vs $75.5M），NLIGHT, INC.同比增速更快（71.3% vs 27.7%），NLIGHT, INC.自由现金流更多（$15.9M vs $14.4M），过去两年NLIGHT, INC.的营收复合增速更高（35.0% vs 31.3%）
nLight Inc.是全球领先的高性能半导体激光器、光纤激光器及相关光学组件研发生产商，产品广泛应用于工业精密制造、航空航天与国防、医疗设备、前沿研究等核心领域，客户遍及北美、欧洲及亚太地区。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
LASR vs PBYI — 直观对比
营收规模更大
LASR
是对方的1.1倍
$75.5M
营收增速更快
LASR
高出43.6%
27.7%
自由现金流更多
LASR
多$1.5M
$14.4M
两年增速更快
LASR
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $81.2M | $75.5M |
| 净利润 | $-4.9M | — |
| 毛利率 | 30.7% | 69.3% |
| 营业利润率 | -6.7% | 22.7% |
| 净利率 | -6.0% | — |
| 营收同比 | 71.3% | 27.7% |
| 净利润同比 | 80.3% | — |
| 每股收益（稀释后） | $-0.10 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LASRPBYI
| Q4 25 | $81.2M | $75.5M | ||
| Q3 25 | $66.7M | $54.5M | ||
| Q2 25 | $61.7M | $52.4M | ||
| Q1 25 | $51.7M | $46.0M | ||
| Q4 24 | $47.4M | $59.1M | ||
| Q3 24 | $56.1M | $80.5M | ||
| Q2 24 | $50.5M | $47.1M | ||
| Q1 24 | $44.5M | $43.8M |
净利润LASRPBYI
| Q4 25 | $-4.9M | — | ||
| Q3 25 | $-6.9M | $8.8M | ||
| Q2 25 | $-3.6M | $5.9M | ||
| Q1 25 | $-8.1M | $3.0M | ||
| Q4 24 | $-25.0M | — | ||
| Q3 24 | $-10.3M | $20.3M | ||
| Q2 24 | $-11.7M | $-4.5M | ||
| Q1 24 | $-13.8M | $-4.8M |
毛利率LASRPBYI
| Q4 25 | 30.7% | 69.3% | ||
| Q3 25 | 31.1% | 77.7% | ||
| Q2 25 | 29.9% | 76.5% | ||
| Q1 25 | 26.7% | 77.1% | ||
| Q4 24 | 2.4% | 76.4% | ||
| Q3 24 | 22.4% | 63.9% | ||
| Q2 24 | 23.5% | 77.4% | ||
| Q1 24 | 16.8% | 75.5% |
营业利润率LASRPBYI
| Q4 25 | -6.7% | 22.7% | ||
| Q3 25 | -10.9% | 17.6% | ||
| Q2 25 | -6.9% | 12.7% | ||
| Q1 25 | -18.6% | 8.7% | ||
| Q4 24 | -55.8% | 22.6% | ||
| Q3 24 | -21.0% | 27.4% | ||
| Q2 24 | -25.1% | -4.6% | ||
| Q1 24 | -33.1% | -5.3% |
净利率LASRPBYI
| Q4 25 | -6.0% | — | ||
| Q3 25 | -10.3% | 16.2% | ||
| Q2 25 | -5.8% | 11.2% | ||
| Q1 25 | -15.7% | 6.5% | ||
| Q4 24 | -52.7% | — | ||
| Q3 24 | -18.4% | 25.2% | ||
| Q2 24 | -23.2% | -9.6% | ||
| Q1 24 | -30.9% | -11.0% |
每股收益（稀释后）LASRPBYI
| Q4 25 | $-0.10 | $0.26 | ||
| Q3 25 | $-0.14 | $0.17 | ||
| Q2 25 | $-0.07 | $0.12 | ||
| Q1 25 | $-0.16 | $0.06 | ||
| Q4 24 | $-0.52 | $0.40 | ||
| Q3 24 | $-0.21 | $0.41 | ||
| Q2 24 | $-0.25 | $-0.09 | ||
| Q1 24 | $-0.29 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.7M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $226.7M | $130.3M |
| 总资产 | $315.2M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资LASRPBYI
| Q4 25 | $98.7M | $97.5M | ||
| Q3 25 | $81.1M | $94.4M | ||
| Q2 25 | $78.8M | $96.0M | ||
| Q1 25 | $82.2M | $93.2M | ||
| Q4 24 | $65.8M | $101.0M | ||
| Q3 24 | $41.5M | $96.7M | ||
| Q2 24 | $49.4M | $96.8M | ||
| Q1 24 | $61.3M | $107.2M |
总债务LASRPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益LASRPBYI
| Q4 25 | $226.7M | $130.3M | ||
| Q3 25 | $218.5M | $115.3M | ||
| Q2 25 | $216.0M | $104.7M | ||
| Q1 25 | $212.8M | $97.1M | ||
| Q4 24 | $216.4M | $92.1M | ||
| Q3 24 | $235.3M | $71.1M | ||
| Q2 24 | $239.5M | $48.5M | ||
| Q1 24 | $244.4M | $51.0M |
总资产LASRPBYI
| Q4 25 | $315.2M | $216.3M | ||
| Q3 25 | $298.7M | $202.9M | ||
| Q2 25 | $295.3M | $194.9M | ||
| Q1 25 | $290.0M | $196.2M | ||
| Q4 24 | $270.2M | $213.3M | ||
| Q3 24 | $291.3M | $220.7M | ||
| Q2 24 | $294.3M | $205.0M | ||
| Q1 24 | $302.8M | $214.1M |
负债/权益比LASRPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $15.9M | $14.4M |
| 自由现金流率自由现金流/营收 | 19.6% | 19.1% |
| 资本支出强度资本支出/营收 | 2.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $12.3M | $41.7M |
8季度趋势，按日历期对齐
经营现金流LASRPBYI
| Q4 25 | $17.5M | $14.4M | ||
| Q3 25 | $5.2M | $9.7M | ||
| Q2 25 | $-1.4M | $14.1M | ||
| Q1 25 | $-20.0K | $3.6M | ||
| Q4 24 | $-3.9M | $15.6M | ||
| Q3 24 | $-5.6M | $11.0M | ||
| Q2 24 | $-4.2M | $1.0M | ||
| Q1 24 | $11.4M | $11.2M |
自由现金流LASRPBYI
| Q4 25 | $15.9M | $14.4M | ||
| Q3 25 | $2.4M | $9.7M | ||
| Q2 25 | $-3.8M | $14.1M | ||
| Q1 25 | $-2.3M | $3.6M | ||
| Q4 24 | $-6.5M | $15.6M | ||
| Q3 24 | $-7.2M | $11.0M | ||
| Q2 24 | $-6.4M | $1.0M | ||
| Q1 24 | $9.8M | — |
自由现金流率LASRPBYI
| Q4 25 | 19.6% | 19.1% | ||
| Q3 25 | 3.7% | 17.7% | ||
| Q2 25 | -6.1% | 26.8% | ||
| Q1 25 | -4.5% | 7.7% | ||
| Q4 24 | -13.7% | 26.4% | ||
| Q3 24 | -12.9% | 13.7% | ||
| Q2 24 | -12.6% | 2.1% | ||
| Q1 24 | 22.1% | — |
资本支出强度LASRPBYI
| Q4 25 | 2.0% | 0.0% | ||
| Q3 25 | 4.2% | 0.0% | ||
| Q2 25 | 3.9% | 0.0% | ||
| Q1 25 | 4.4% | 0.1% | ||
| Q4 24 | 5.5% | 0.0% | ||
| Q3 24 | 2.9% | 0.0% | ||
| Q2 24 | 4.2% | 0.0% | ||
| Q1 24 | 3.5% | 0.0% |
现金转化率LASRPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LASR
| Aerospaceand Defense | $56.3M | 69% |
| Microfabrication | $14.2M | 18% |
| Industrial | $10.7M | 13% |
PBYI
暂无分部数据
